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Background: Although the harms of smoking are well established, it is unclear how they extend into old age
in the Chinese.
Aim: To examine the relationship of smoking with all-cause and major cause-specific mortality in elderly
Chinese men and women, respectively, in Hong Kong.
Methods: Mortality by smoking status was examined in a prospective cohort study of 56 167 (18 749 men,
37 416 women) Chinese aged >65 years enrolled from 1998 to 2000 at all the 18 elderly health centres of
the Hong Kong Government Department of Health.
Results: After a mean follow-up of 4.1 years, 1848 male and 2035 female deaths occured among 54 214
subjects (96.5% successful follow-up). At baseline, more men than women were current smokers (20.3% vs
4.0%) and former smokers (40.8% vs 7.9%). The adjusted RRs (95% CI) for all-cause mortality in former and
current smokers, compared with never smokers, were 1.39 (1.23 to 1.56) and 1.75 (1.53 to 2.00) in men
and 1.43 (1.25 to 1.64) and 1.38 (1.14 to 1.68) in women, respectively. For current smokers, the RRs (95%
CI) for all-cause mortality were 1.59 (1.39 to 1.82), 1.72 (1.48 to 2.00) and 1.84 (1.43 to 2.35) for daily
consumption of 1–9, 10–20 and .21 cigarettes, respectively (p for trend ,0.001). RRs (95% CI) were 1.49
(1.30 to 1.72) and 2.20 (1.88 to 2.57) in former and current smokers for all deaths from cancer, and 1.24
(1.04 to 1.47) and 1.57 (1.28 to 1.94) for all cardiovascular deaths, respectively. Quitters had significantly
lower risks of death than current smokers from all causes, lung cancer, all cancers, stroke and all
cardiovascular diseases.
Conclusions: In old age, smoking continues to be a major cause of death, and quitting is beneficial. Smoking
cessation is urgently needed in rapidly ageing populations in the East.
M
any Western prospective studies have shown that much
of the all-cause mortality, including lung cancer,
cardiovascular disease (CVD) and chronic obstructive
pulmonary disease (COPD) are caused by cigarette smoking.1–3
Globally, tobacco-related deaths are rising, mainly because of
increasing cigarette consumption in developing countries,
especially China.4
Prospective studies of smoking and mortality in China are
few,5–9 and evidence from elderly people, especially women, is
sparse. Some Western studies have found a lower risk of
mortality from smoking in old age than in middle age.10 11
Prospective studies are needed to monitor the growing tobacco
epidemic particularly in rapidly developing regions and rapidly
ageing populations. However, these populations, including
mainland Chinese, are mostly in the early stage of the epidemic,
and prospective studies8 would underestimate the risks,
especially in elderly smokers. In Hong Kong, with a largely
ethnic Chinese population, tobacco consumption reached its
peak about 20 years earlier than in mainland China, but about
20 years later than in developed Western countries, such as the
US.12–14 Evidence from elderly Chinese in Hong Kong can
forewarn what will happen to their counterparts in the rest of
China and also in other developing Asian countries. Only two
papers, one from a large community-based case–control study14
and the other from a small prospective study,15 have reported
the association between smoking and mortality in elderly
Chinese in Hong Kong. This prospective study examined the
relationship of smoking with all-cause and major cause-specific
mortality in elderly Chinese men and women, respectively, in
Hong Kong.
METHODS
Sample
Since July 1998, 18 Elderly Health Centres have been
established to provide health examination and primary care
services by the Department of Health of the Government of the
Hong Kong Special Administrative Region. All elderly people
aged >65 years were encouraged to enroll at a nominal fee,
which was waived for the poor. All 56 167 clients who first
enrolled from July 1998 to December 2000 were included,
almost all were community-dwelling older people and a
minority lived in institutions (4.3%). Details of the methods
have been reported previously.16 17 Smoking was defined as ‘‘at
least one cigarette per day continuously for at least 1 year’’.
Current smokers were people who had ever smoked and who
were still smoking at baseline. Former smokers were ever
smokers who had stopped smoking for at least 1 year. Never
smokers were those who had never smoked at least one
cigarette a day continuously for at least 1 year.
Follow-up
Vital status and causes of death by 31 December 2003 were
ascertained from official death registration, specialist out-
patient and hospitalisation databases by linking the unique
identity card number of every client. Failing these, the subjects
were followed up by telephone interview from November 2004
to January 2005. This yielded a mean (SD) follow-up duration
of 4.1 (0.9) years among 54 216 subjects, with 1951 (3.5%) lost
Abbreviations: COPD, chronic obstructive pulmonary disease; CVD,
cardiovascular disease
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to follow-up. By the end of 2003, 50 332 were still alive and
3884 deaths had occurred, 3829 of known causes and 55 of
unknown causes. In addition to the 1951 subjects lost to follow-
up, 2 subjects without a smoking status were also excluded,
leaving 54 214 older people and 3883 deaths (1848 men and
2035 women) for analysis. Causes of death obtained for 3829
subjects were routinely coded by the governmental Department
of Health according to the International classification of diseases—
9th revision before 2001 and 10th revision in and after 2001.
Statistical analysis
A Cox proportional hazards model was used to estimate the
relative risks (RRs, or hazard ratio) and the 95% CIs of all-cause
and cause-specific mortality by smoking status (never smoker as
the reference group), with adjustment for potential baseline
confounders. The proportional hazards assumption was checked
by visual inspection of plots of log (2log (S)) against time, where
S was the estimated survival function. For cause-specific mortality
analyses, subjects who died of other causes or unknown causes
were regarded as censored at the date of death.18 19 The
population-attributable risk percentage (for all the study subjects)
for all-cause mortality was based on the formula (Pe (RR21)/1+Pe
(RR21)), where Pe was the prevalence of ever smoking and RR
the adjusted RR for all-cause mortality. All statistical analyses
were performed using SPSS V.13.0. Ethical approval was obtained
from the ethics committee of the Li Ka Shing Faculty of Medicine,
The University of Hong Kong, Pokfulam, Hong Kong. The study
complied with the principles of the Declaration of Helsinki.
Table 1 Baseline characteristics of 54 214 clients in Elderly Health Centres in Hong Kong by sex and smoking status
Men Women
Characteristics
Never smoker,
n (%)
Former smoker,
n (%)
Current smoker,
n (%) x2 p Value
Never smoker,
n (%)
Former smoker,
n (%)
Current smoker,
n (%) x2 p Value
Sex 7072 (38.9) 7455 (41.0) 3635 (20.0) 31767 (88.1) 2853 (7.9) 1432 (4.0)
Age (years) ,0.001 ,0.001
65–69 3043 (43.0) 2520 (33.8) 1497 (41.2) 13127 (41.3) 681 (23.9) 463 (32.3)
70–74 2156 (30.5) 2487 (33.4) 1218 (33.5) 9595 (30.2) 845 (29.6) 479 (33.4)
75–79 1164 (16.5) 1561 (20.9) 626 (17.2) 5615 (17.7) 726 (25.4) 310 (21.6)
>80 709 (10.0) 887 (11.9) 294 (8.1) 3430 (10.8) 601 (21.1) 180 (12.6)
Education ,0.001 ,0.001
Secondary or above 2686 (38.0) 1998 (26.8) 809 (22.3) 3239 (10.2) 156 (5.5) 92 (6.4)
Primary 3377 (47.8) 4053 (54.4) 1988 (54.7) 9358 (29.5) 786 (27.5) 370 (25.8)
No formal education but
can read and write
565 (8.0) 840 (11.3) 470 (12.9) 6301 (19.8) 657 (23) 304 (21.2)
Illiterate 444 (6.3) 564 (7.6) 389 (10.2) 12869 (40.5) 1254 (44) 666 (46.5)
Ever alcoholic 2175 (30.8) 4667 (62.6) 2119 (58.3) ,0.001 3747 (11.8) 1038 (36.4) 420 (29.3) ,0.001
Regular exercise 6064 (85.8) 6344 (85.1) 2696 (74.2) ,0.001 27346 (86.1) 2427 (85.1) 1066 (74.4) ,0.001
Active chronic diseases
Hypertension 2655 (37.5) 2683 (36.0) 920 (25.3) ,0.001 11995 (37.6) 1050 (36.8) 347 (24.2) ,0.001
Diabetes mellitus 928 (13.1) 966 (13.0) 341 (9.4) ,0.001 4078 (12.8) 367 (12.9) 127 (8.9) ,0.001
Heart disease 810 (11.5) 1045 (14.0) 299 (8.2) ,0.001 4156 (13.1) 442 (15.5) 150 (10.5) ,0.001
COPD/asthma 272 (3.8) 842 (11.3) 370 (10.2) ,0.001 1147 (3.6) 362 (12.7) 134 (9.4) ,0.001
Hypercholesterolaemia 892 (12.6) 925 (12.4) 313 (8.6) ,0.001 5763 (18.1) 520 (18.2) 162 (11.3) ,0.001
Cerebrovascular accident 243 (3.4) 364 (4.9) 116 (3.2) ,0.001 866 (2.7) 88 (3.1) 38 (2.7) 0.520
Medication taken regularly 3776 (53.4) 4287 (57.5) 1529 (42.1) ,0.001 17228 (54.2) 1676 (58.7) 613 (42.8) ,0.001
Any admission to hospital in
the last year
895 (12.7) 1240 (16.6) 451 (12.4) ,0.001 3965 (12.5) 482 (16.9) 156 (10.9) ,0.001
Unintentional weight loss >10 lb
during the past 6 months
170 (2.4) 246 (3.3) 120 (3.3) 0.001 747 (2.4) 110 (3.9) 51 (3.6) ,0.001
Monthly personal expenditure
(US$1 = HK$7.814)
,0.001 ,0.001
,HK$1000 (£65, J96) 834 (11.8) 972 (13.0) 378 (10.4) 5357 (16.9) 509 (17.8) 282 (19.7)
HK$1000–1999 (£65–130,
J96–192)
2549 (36.0) 2778 (37.3) 1288 (35.4) 12648 (39.8) 1026 (36.0) 505 (35.3)
HK$>2000 (£130, J192) 3689 (52.2) 3705 (49.7) 1969 (54.2) 13759 (43.3) 1318 (46.2) 645 (45.0)
Regular contact with relatives 6869 (97.1) 7204 (96.6) 3466 (95.4) ,0.001 30979 (97.5) 2726 (95.5) 1379 (96.3) ,0.001
BMI category (kg/m2) ,0.001 ,0.001
,18.5 (underweight) 325 (4.6) 391 (5.3) 345 (9.5) 1438 (4.5) 240 (8.4) 222 (15.5)
18.5–22.9 (normal weight) 2178 (30.9) 2371 (31.9) 1526 (42.0) 9635 (30.4) 904 (31.8) 529 (36.9)
23.0–24.9 (at risk of obesity) 1782 (25.2) 1819 (24.5) 733 (20.2) 6971 (22.0) 573 (20.1) 265 (18.5)
25.0–29.9 (obesity I) 2480 (35.1) 2556 (34.4) 920 (25.3) 11219 (35.4) 947 (33.3) 343 (24.0)
>30.0 (obesity II) 293 (4.2) 300 (4) 108 (3.0) 2425 (7.7) 180 (6.3) 73 (5.1)
Self-rated health ,0.001 ,0.001
Better 2113 (29.9) 2201 (29.5) 1087 (29.9) 6498 (20.5) 664 (23.3) 303 (21.2)
Normal 4637 (65.6) 4811 (64.5) 2322 (63.9) 22444 (70.7) 1876 (65.8) 1006 (70.3)
Worse 321 (4.5) 443 (5.9) 226 (6.2) 2822 (8.9) 313 (11.0) 123 (8.6)
Functional disability 318 (4.5) 473 (6.3) 178 (4.9) ,0.001 2675 (8.4) 367 (12.9) 121 (8.4) ,0.001
Depressive symptoms 260 (3.7) 370 (5.0) 256 (7.0) ,0.001 2366 (7.5) 309 (10.9) 164 (11.5) ,0.001
BMI, body mass index; COPD, chronic obstructive pulmonary disease.
Subjects with missing data were excluded.
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RESULTS
Characteristics of subjects at baseline
We compared (a) the baseline data of age, education and
smoking patterns in our cohort with the census and general
population data, and (b) the proportionate mortality of major
causes of deaths in our cohort with the Hong Kong Death
Registry population data. More women than men enrolled in
the study; however, for each sex the Cohen effect sizes20 were
small,17 suggesting that even if our cohort, made up of
volunteers, might be more health conscious, it should be
reasonably representative of the general population of the same
age in terms of basic demographic characteristics and mortality
outcomes. The mean (SD) age of 18 162 men and 36 052
women at baseline were 72.8 (5.4) and 73.1 (5.8) years. There
were more male than female current smokers (20.0% vs 4.0%)
and former smokers (41.0% vs 7.9%; p,0.001). Table 1 shows
that there were more current smokers than never smokers who
drank alcohol, did not exercise regularly, had unintentional
weight loss in the past 6 months, rated their health as worse,
had depressive symptoms and had lower body mass index in
both sexes.
Mortality by smoking status
Table 2 shows that in men and women, the mortality in former
and current-smokers was higher than that in never smokers.
Table 3 shows that in men, after adjusting for potential baseline
confounders, current smokers and former smokers had signifi-
cantly higher risks of death from lung cancer than never smokers
(RR 6.66, 95% CI 4.41 to 10.06; RR 3.30, 95% CI 2.19 to 4.98), all
cancers (RR 2.52, 95% CI 2.05 to 3.10; RR 1.65, 95% CI 1.36 to
2.00) and all causes (RR 1.75, 95% CI 1.53 to 2.00; RR 1.39, 95% CI
1.23 to 1.56). Current smokers also had a significantly higher risk
of death from stroke than never smokers (RR 2.07, 95% CI 1.30 to
3.29) and all CVDs (RR 1.54, 95% CI 1.18 to 2.02), but former
smokers did not. Former smokers showed higher risks of death
from COPD than never smokers (RR 1.72, 95% CI 1.06 to 2.80)
and all respiratory diseases (RR 1.39, 95% CI 1.04 to 1.87), but
current smokers did not. Significant positive linear trends were
also found between increasing smoking status (from never
smokers, former smokers and current smokers who consumed 1–
9, 10–20 and .20 cigarettes daily) and risks of death from lung
cancer, all cancers, stroke, all CVDs and all causes. Similar results
were also found in women.
Table 2 Crude mortality (per 100 000 person-years) of 54 214 clients in Elderly Health Centres in Hong Kong by sex and
smoking status
Never smoker Former smoker
Current smoker (cigarettes per day)
All current smoker 1–9* 10–20* .20*
Cause of death n Mortality n Mortality n Mortality n Mortality n Mortality n Mortality
Men
Subjects 7072 7455 3635 1391 1547 564
Person-years 29136 29856 14299 5557 6126 2018
Malignant neoplasm
Lung cancer 31 106 112 375 116 811 42 756 54 882 18 892
All cancers 179 614 321 1075 241 1685 92 1656 109 1779 34 1685
Cardiovascular disease
Ischaemic heart
disease
67 230 83 278 40 280 15 270 19 310 6 297
Stroke 42 144 71 238 40 280 17 306 17 278 4 198
All cardiovascular
disease
143 491 218 730 103 720 43 774 46 751 12 595
Respiratory disease
COPD 24 82 95 318 30 210 17 306 7 114 6 297
All respiratory
diseases
80 275 192 643 61 427 30 540 20 326 10 496
All causes 508 1744 869 2911 471 3294 202 3635 193 3151 66 3271
Women
Subjects 31767 2853 1432 892 374 78
Person-years 133270 11804 5910 3703 1513 298
Malignant neoplasm
Lung cancer 162 122 52 441 29 491 21 567 6 396 0 0
All cancers 615 461 101 856 52 880 35 945 13 859 0 0
Cardiovascular disease
Ischaemic heart
disease
181 136 29 246 13 220 6 162 4 264 2 671
Stroke 183 137 32 271 13 220 8 216 2 132 2 671
All cardiovascular
disease
484 363 81 686 33 558 20 540 6 396 4 1343
Respiratory disease
COPD 35 26 38 322 9 152 5 135 1 66 1 336
All respiratory
diseases
171 128 64 542 16 271 10 270 3 198 1 336
All causes 1622 1217 299 2533 114 1929 75 2025 24 1586 5 1678
COPD, chronic obstructive pulmonary disease.
*Subjects with missing data on cigarette consumption daily were excluded.
Includes COPD, respiratory tuberculosis and other respiratory diseases.
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Effects of quitting on mortality
For men, former smokers had significantly lower risks of death
from lung cancer (RR 0.51, 95% CI 0.39 to 0.67), all cancers (RR
0.64, 95% CI 0.54 to 0.77), stroke (RR 0.63, 95% CI 0.41 to 0.95)
and all causes (RR 0.81, 95% CI 0.72 to 0.91) than current
smokers. For women, quitting also reduced risks of mortality
from lung cancer, all cancers, ischaemic heart disease, stroke
and all CVDs, although the differences were not significant
(table 4). However, higher risks of death from COPD were
found in former smokers in men and women.
Excluding those who died soon after their first
enrolment
When the analyses were repeated after excluding 244 deaths
within 6 months of their first enrolment to reduce the ‘‘ill
quitter effect’’ or ‘‘healthy smoker effect’’, similar results were
observed; but the risks of death from COPD (RR 1.43, 95% CI
0.97 to 2.12) and all respiratory diseases (RR 1.30, 95% CI 0.99
to 1.72) in former smokers became insignificant (tables 5 and
6).
Population-attributable risk percentage for all-cause
mortality
Table 3 shows that male and female ever smokers (combining
current and former smokers) had 50% and 42% higher risks of
all-cause death, respectively. The population-attributable frac-
tions for all-cause mortality were 23.4% (95% CI 22.8% to
24.0%) for men and 4.8% (95% CI 4.5% to 5.0%) for women.
DISCUSSION
Most prospective studies on smoking and mortality are on
middle-aged subjects, and have clearly shown that smoking is
associated with increased risks of all-cause mortality and cause-
specific mortality from CVDs, cancer and respiratory diseases,
including the American Cancer Society Cancer Prevention
Study 2 data used to estimate deaths attributable to smoking
in the US.21 Far fewer studies have focused on older people,
especially older women, and the results are inconsistent. Some
found that the effects of smoking on mortality in elderly people
were similar to those in middle-aged people,22 23 but others
showed no statistically or only marginally significantly
Table 3 Adjusted RR with 95% CI for all-cause and cause-specific death by smoking status of clients in Elderly Health Centres in
Hong Kong
Cause of deaths
Never
smoker Former smoker All current smoker
Cigarette consumption per day for current smoker
Linear test for
trend 1
Linear test
for trend 2` Ever smoker11–9 10–20 .20
RR RR (95% CI) RR (95% CI) RR (95% CI) RR (95% CI) RR (95% CI) p Value p Value RR (95% CI)
Men
Malignant neoplasm
Lung cancer 1.00 3.30*** (2.19 to
4.98)
6.66*** (4.41 to
10.06)
6.07*** (3.77 to
9.77)
7.40*** (4.67 to
11.73)
7.52*** (4.13 to
13.70)
,0.001 ,0.001 4.42*** (3.00 to
6.51)
All cancers 1.00 1.65*** (1.36 to
2.00)
2.52*** (2.05 to
3.10)
2.34*** (1.81 to
3.04)
2.77*** (2.15 to
3.56)
2.58*** (1.76 to
3.78)
,0.001 ,0.001 1.93*** (1.61 to
2.31)
Cardiovascular disease
CHD 1.00 0.89 (0.63 to
1.27)
1.20 (0.79 to
1.83)
1.10 (0.62 to
1.96)
1.38 (0.81 to
2.37)
1.47 (0.62 to
3.47)
0.51 0.19 0.98 (0.71 to
1.36)
Stroke 1.00 1.33 (0.88 to
2.02)
2.07** (1.30 to
3.29)
1.98* (1.10 to
3.55)
2.26** (1.25 to
4.09)
1.65 (0.58 to
4.73)
0.002 0.005 1.55* (1.05 to
2.28)
All 1.00 1.20 (0.95 to
1.50)
1.54** (1.18 to
2.02)
1.52* (1.07 to
2.16)
1.70** (1.20 to
2.41)
1.43 (0.78 to
2.62)
0.002 0.002 1.29* (1.04 to
1.60)
Respiratory disease
COPD 1.00 1.72* (1.06 to
2.80)
1.19 (0.67 to
2.14)
1.53 (0.78 to
2.98)
0.67 (0.28 to
1.62)
2.24 (0.89 to
5.68)
0.68 0.94 1.56 (0.97 to
2.51)
All 1.00 1.39* (1.04 to
1.87)
1.12 (0.78 to
1.61)
1.21 (0.77 to
1.88)
0.93 (0.56 to
1.55)
1.52 (0.77 to
3.00)
0.47 0.68 1.31 (0.99 to
1.74)
All causes 1.00 1.39*** (1.23 to
1.56)
1.75*** (1.53 to
2.00)
1.75*** (1.47 to
2.07)
1.78*** (1.50 to
2.12)
1.87*** (1.44 to
2.45)
,0.001 ,0.001 1.50*** (1.34 to
1.67)
Women
Malignant neoplasm
Lung cancer 1.00 2.74*** (1.95 to
3.83)
3.19*** (2.11 to
4.83)
3.44*** (2.14 to
5.52)
2.85* (1.25 to
6.51)
Undetermined ,0.001 ,0.001 2.89*** (2.16 to
3.86)
All cancers 1.00 1.42** (1.14 to
1.78)
1.66** (1.24 to
2.23)
1.68** (1.18 to
2.38)
1.79* (1.03 to
3.12)
Undetermined ,0.001 ,0.001 1.50*** (1.24 to
1.81)
Cardiovascular disease
CHD 1.00 1.20 (0.79 to
1.83)
1.58 (0.89 to
2.81)
1.04 (0.46 to
2.38)
2.44 (0.90 to
6.64)
6.64* (1.62 to
27.17
0.096 0.029 1.30 (0.91 to
1.87)
Stroke 1.00 1.31 (0.87 to
1.99)
1.60 (0.90 to
2.86)
1.41 (0.69 to
2.91)
1.17 (0.29 to
4.74)
6.87** (1.68 to
28.06
0.054 0.033 1.39 (0.97 to
1.99)
All 1.00 1.28 (0.99 to
1.66)
1.56* (1.09 to
2.24)
1.36 (0.86 to
2.14)
1.37 (0.61 to
3.09)
5.07** (1.88 to
13.68
0.004 0.002 1.36** (1.09 to
1.70)
Respiratory disease
COPD 1.00 3.84*** (2.26 to
6.51)
2.37* (1.07 to
5.24)
1.78 (0.66 to
4.82)
1.16 (0.15 to
8.83)
7.92 (1.00 to
62.75)
,0.001 0.002 3.41*** (2.06 to
5.63)
All respiratory diseases 1.00 2.07*** (1.48 to
2.88)
1.39 (0.80 to
2.41)
1.14 (0.57 to
2.29)
1.38 (0.43 to
4.37)
3.33 (0.46 to
24.24)
0.002 0.005 1.87*** (1.38 to
2.54)
All causes 1.00 1.43*** (1.25 to
1.64)
1.38** (1.14 to
1.68)
1.31* (1.04 to
1.67)
1.37 (0.91 to
2.05)
1.59 (0.66 to
3.85)
,0.001 ,0.001 1.42*** (1.26 to
1.59)
CHD, coronary heart disease; COPD, chronic obstructive pulmonary disease.
*p,0.05, **p,0.01, ***p,0.001.
Linear trend with increasing smoking status from never, former and current smokers.
`Linear trend with increasing smoking status from never smoker, former smoker and current smoker who consumed 1–9, 10–20 and >21 cigarettes daily.
1Combining current smoker and former smoker.
Adjusted for age, education, alcohol consumption, physical exercise and active chronic diseases: hypertension, diabetes mellitus, heart diseases, COPD/asthma, hypercholesterolaemia, cerebrovascular accident,
regular medication, admission to hospital, monthly expenditure, regular contact with relatives, unintentional weight loss in the past 6 months, body mass index, self-rated health, functional disability and depressive
symptoms.
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increased risks of mortality.10 24 The results for former smokers
are more controversial. Some studies combined former smokers
with current smokers, and few potentially confounding
variables were adjusted for. Some studies suggest that even
among elderly people, the effects of smoking on mortality may
differ between younger-old and older-old people.10 11 The
questions above need to be clarified in Western countries and
also in developing countries, where populations are ageing
rapidly and smoking has become more popular, especially in
China, in which 30% of the world’s cigarettes are consumed.25 26
In mainland China, only one prospective study reported the
detrimental effect of smoking on mortality in 1268 retired men
in Xi’an.9 At present, the epidemic of smoking-related mortality
in China is still in its early stages. Prospective evidence from
Hong Kong, which is at a fairly advanced stage of an epidemic
of tobacco deaths, can forewarn the growing epidemic in
mainland China and Asia in the next few decades and support
early intervention.
The present study consistently shows that both current and
former smoking significantly increased the risks of all-cause
death with dose–response relationships by daily cigarette
consumption for both male and female older Chinese in Hong
Kong. The RRs for current smokers were about 1.8 in men and
1.4 in women, which were slightly lower than those from
Western countries, but higher than those previously reported
from mainland China. LaCroix et al10 and Paganini-Hill and
Hsu23 reported an RR of about 2.0 for older men in the US,
whereas Vogt et al11 reported an RR of about 1.7–2.2 for older
women. The prospective study from Xi’an by Lam et al9 revealed
an RR of 1.5 for older men. However, the only previous Hong
Kong elderly cohort study by Ho et al15 did not find statistically
significantly increased risks of all-cause death for both male
and female current smokers, but the sample size (999 men and
1033 women) was small and the duration of follow-up
(3 years) was short.
Our elderly former smokers also showed increased RRs of 1.4
for all-cause mortality in both sexes (p,0.001). LaCroix et al10
found a similar RR of 1.5 in male quitters, but the RR was
insignificant in women. Paganini-Hill and Hsu23 found lower
risks than ours, with significant RRs of 1.2 in both male and
female former smokers. Although Lam et al9 did not find a
significantly higher risk of mortality in male former smokers in
Xi’an, China, they found similar results for ever smokers aged
>70 years in a large case–control study in Hong Kong, with
odds ratios of 1.4 in men and 1.7 in women.14 It should be noted
that the comparison of RRs of studies with different age
distributions could be problematic if RR varies by age.
We found significantly higher risks for all cancers and lung
cancer in current smokers and also in former smokers, while
most other elderly cohort studies only found the risks in current
smokers but not in former smokers.9–11 15 22
Although smoking can cause ischaemic heart disease and
CVDs, whether and to what extent the effects extend to those
who have survived to old age need to be further examined. The
Framingham Heart Study, with 30 years of follow-up, reported
that there was no significant relationship between cigarette
smoking and the incidence of and mortality from ischaemic
heart disease,24 27 although the American Cancer Society Cancer
Prevention Study 2 did find increased mortality from ischaemic
heart disease in both younger and older smokers.21 For men and
women separately, we did not find any statistically significant
association between smoking (both current smoking and
former smoking) and mortality from ischaemic heart disease.
But for female current smokers who consumed .20 cigarettes
daily, we found a significantly increased risk, with a significant
linear trend. Combining men and women, we found a
significant linear trend between smoking and risk of mortality
from ischaemic heart disease. If ischaemic heart disease tends
to kill Chinese smokers at a younger age than other diseases,
the excess risks from smoking in elderly Chinese people would
be much lower because of a survivor effect.
Our male current smokers also showed a higher risk of death
from stroke, which was consistent with studies from the
West2 21 28 29, whereas previous studies on Chinese did not find
such a relationship.5–7 9 14 This was also true for our female
heavy smokers who smoked .20 cigarettes daily. We also
found that only current smoking, but not former smoking,
increased the risk of death from all CVDs for both men and
women, with dose–response relationships. Further studies are
needed in different countries on how interactions of smoking
with different cultures and lifestyles affect stroke and heart
disease in middle age and in old age.
Our finding of higher risks of mortality from COPD in former
smokers than in current smokers is consistent with other
Table 4 Adjusted RR (95% CI) for all-cause mortality and cause-specific mortality for quitting
from smoking (former smokers compared with current smokers) of clients in Elderly Health
Centres in Hong Kong
Cause of death
Men Women Total`
RR (95% CI) RR (95% CI) RR (95% CI)
Malignant neoplasm
Lung cancer 0.51*** (0.39 to 0.67) 0.86 (0.53 to 1.41) 0.58*** (0.46 to 0.73)
All cancers 0.64*** (0.54 to 0.77) 0.89 (0.63 to 1.28) 0.69*** (0.59 to 0.80)
Cardiovascular disease
Ischaemic heart disease 0.75 (0.50 to 1.12) 0.81 (0.40 to 1.63) 0.77 (0.54 to 1.09)
Stroke 0.63* (0.41 to 0.95) 0.68 (0.33 to 1.38) 0.67* (0.47 to 0.95)
All cardiovascular 0.78 (0.61 to 1.00) 0.8 (0.52 to 1.23) 0.79* (0.64 to 0.98)
Respiratory disease
COPD 1.42 (0.91 to 2.22) 1.86 (0.85 to 4.07) 1.49* (1.02 to 2.18)
All respiratory 1.22 (0.90 to 1.66) 1.68 (0.91 to 3.08) 1.32* (1.01 to 1.73)
All causes 0.79*** (0.70 to 0.89) 1.04 (0.82 to 1.31) 0.84** (0.75 to 0.93)
*p,0.05, **p,0.01, ***p,0.001.
Adjusted for age, education, alcohol consumption, physical exercise and active chronic diseases: hypertension,
diabetes mellitus, heart disease, chronic obstructive pulmonary disease/asthma, hypercholesterolaemia, cerebrovascular
accident, regular medication, admission to hospital, monthly personal expenditure, regular contact with relatives,
unintentional weight loss in the past 6 months, body mass index, self-rated health, functional disability and depressive
symptoms.
`Adjusted for sex and the variables above.
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findings.9 30 Female but not male current smokers also showed
higher risks of death from COPD than never smokers, which
was also consistent with studies from Lam et al9 and Vogt et al.11
Some authors explained this by either the healthy smoker effect
or the ill quitter effect, or both, because older smokers were
survivors with probably less serious disease and those
susceptible to COPD would have died earlier.9 To reduce bias
due to reverse causality, we carried out further analyses after
excluding those who had died soon after their first enrolment—
that is, within 6 months—and the excess risks of death from
COPD and all respiratory diseases in former smokers, compared
with current smokers, became insignificant. Some have
suggested that a reduction in the risk of mortality from COPD
was observed only in those who had quit smoking for
.10 years,30 but we could not examine the effect of years of
quitting as data were not available.
We found significant effects of quitting; male former
smokers had lower risks of mortality from all causes, lung
cancer, all cancers and stroke than current smokers. Similar
patterns were also found in women, although the reduced risks
were not statistically significant, probably because of the small
number of deaths. In short, all the available evidence, including
ours, has consistently shown substantial benefits of quitting
smoking even in elderly people, confirming that quitting is not
too late, even after the age of 65.
One limitation of our study is that the period of follow-up
was relatively short, but the number of deaths was enough to
test some important hypotheses. In China and other developing
countries where knowledge about the hazards of smoking is
low, there is a common misbelief that smoking among elderly
people is not that harmful (which is apparently supported by
lower RRs due to a survivor effect) and that quitting may cause
more harm (possibly due to reverse causality), particularly for
COPD, which is a more common cause of death in China than
in the West.8 9 Our results support the development of a strong
smoking cessation policy. Volunteer bias is another possible
Table 5 Adjusted RR with 95% CI for all-cause and cause-specific death by smoking status of clients in Elderly Health Centres in
Hong Kong after excluding 244 deaths, people who died within 6 months after their first enrolment
Cause of deaths
Never
smoker Former smoker All current smoker
Cigarette consumption per day for current smoker
Linear test
for trend 1
Linear test
for trend 2` Ever smoker11–9 10–20 .20
RR RR (95% CI) RR (95% CI) RR (95% CI) RR (95% CI) RR (95% CI) p Value p Value RR (95% CI)
Men
Malignant neoplasm
Lung cancer 1.00 3.36*** (2.20 to
5.13)
6.65*** (4.34 to
10.18)
6.17*** (3.78 to
10.07)
7.35*** (4.56 to
11.83)
7.24*** (3.86 to
13.59)
,0.001 ,0.001 4.45*** (2.98 to
6.64)
All cancers 1.00 1.65*** (1.35 to
2.01)
2.48*** (2.00 to
3.07)
2.35*** (1.79 to
3.07)
2.66*** (2.05 to
3.46)
2.57*** (1.72 to
3.83)
,0.001 ,0.001 1.92*** (1.59 to
2.30)
Cardiovascular disease
CHD 1.00 0.88 (0.62 to
1.27)
1.17 (0.75 to
1.80)
1.01 (0.55 to
1.86)
1.37 (0.79 to
2.38)
1.54 (0.65 to
3.66)
0.624 0.223 0.96 (0.69 to
1.35)
Stroke 1.00 1.59* (1.01 to
2.50)
2.56*** (1.56 to
4.22)
2.26* (1.20 to
4.24)
2.98** (1.61 to
5.54)
2.22 (0.76 to
6.48)
,0.001 ,0.001 1.87** (1.22 to
2.85)
All 1.00 1.26 (0.99 to
1.60)
1.60** (1.20 to
2.12)
1.47* (1.01 to
2.14)
1.87** (1.31 to
2.68)
1.49 (0.79 to
2.80)
0.001 0.001 1.35** (1.08 to
1.70)
Respiratory disease
COPD 1.00 1.78* (1.08 to
2.96)
1.24 (0.68 to
2.26)
1.53 (0.76 to
3.06)
0.73 (0.30 to
1.77)
2.41 (0.94 to
6.16)
0.629 0.832 1.61 (0.98 to
2.65)
All 1.00 1.38* (1.02 to
1.86)
1.12 (0.77 to
1.61)
1.16 (0.73 to
1.83)
0.95 (0.57 to
1.60)
1.59 (0.80 to
3.13)
0.495 0.633 1.30 (0.98 to
1.74)
All causes 1.00 1.40*** (1.24 to
1.58)
1.75*** (1.52 to
2.01)
1.74*** (1.46 to
2.07)
1.80*** (1.50 to
2.16)
1.86*** (1.41 to
2.45)
,0.001 ,0.001 1.51*** (1.34 to
1.69)
Women
Malignant neoplasm
Lung cancer 1.00 2.77*** (1.95 to
3.92)
3.25*** (2.11 to
4.99)
3.40*** (2.07 to
5.59)
3.11** (1.36 to
7.12)
Undetermined ,0.001 ,0.001 2.93*** (2.17 to
3.95)
All cancers 1.00 1.46** (1.16 to
1.84)
1.73*** (1.28 to
2.33)
1.69** (1.17 to
2.43)
1.98* (1.13 to
3.45)
Undetermined ,0.001 ,0.001 1.54*** (1.27 to
1.88)
Cardiovascular disease
CHD 1.00 1.30 (0.85 to
2.00)
1.47 (0.79 to
2.74)
0.95 (0.39 to
2.34)
2.00 (0.63 to
6.33)
7.30** (1.78 to
29.97)
0.112 0.043 1.35 (0.93 to
1.96)
Stroke 1.00 1.39 (0.91 to
2.12)
1.46 (0.78 to
2.73)
1.13 (0.50 to
2.60)
1.26 (0.31 to
5.13)
7.73** (1.89 to
31.66)
0.084 0.047 1.41 (0.97 to
2.05)
All 1.00 1.37* (1.05 to
1.78)
1.48* (1.01 to
2.18)
1.24 (0.76 to
2.04)
1.23 (0.51 to
2.99)
5.62** (2.08 to
15.16)
0.005 0.003 1.40** (1.11 to
1.76)
Respiratory disease
COPD 1.00 3.72*** (2.14 to
6.45)
2.54* (1.14 to
5.66)
1.92 (0.70 to
5.23)
1.21 (0.16 to
9.20)
8.51* (1.07 to
67.83)
,0.001 0.002 3.37*** (2.00 to
5.66)
All 1.00 2.08*** (1.48 to
2.93)
1.42 (0.80 to
2.52)
1.36 (0.63 to
2.52)
1.01 (0.25 to
4.11)
3.58 (0.49 to
26.11)
0.002 0.008 1.89*** (1.38 to
2.60)
All causes 1.00 1.46*** (1.27 to
1.67)
1.37** (1.12 to
1.68)
1.28 (1.00 to
1.65)
1.36 (0.89 to
2.07)
1.74 (0.72 to
4.20)
,0.001 ,0.001 1.43*** (1.27 to
1.62)
CHD, coronary heart disease; COPD, chronic obstructive pulmonary disease.
*p,0.05, **p,0.01, ***p,0.001.
Linear trend with increasing smoking status from never to former and current smoker.
`Linear trend with increasing smoking status from never smoker, former smoker and current smoker consuming 1–9, 10–20, and 21 cigarettes or more daily.
1Combining current smoker and former smoker.
Adjusted for age, education, alcohol consumption, physical exercise, active chronic diseases: hypertension, diabetes mellitus, heart diseases, COPD/asthma, hypercholesterolaemia,
cerebrovascular accident, regular medication, admission to hospital, monthly expenditure, regular contact with relatives, unintentional weight loss in the past 6 months, body mass index, self-rated
health, functional disability and depressive symptoms.
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limitation as all the subjects were attendees at a primary care
facility. The Elderly Health Centres tend to attract healthier
clients who voluntarily come to the clinics, so the risks of
smoking in the general elderly population in Hong Kong might
be underestimated. As the Cohen effect sizes for baseline
demographic characteristics and proportionate mortality were
small, this bias should not be substantial.
Our study had several strengths. The mortality data are
available from the death registry database, which is checked
regularly by the Department of Health. Records were linked
using the unique Hong Kong identification number. Almost all
deaths in Hong Kong are certified by doctors in the hospital,
and validity and completeness of the causes of death should be
good, especially within the broad categorisation that we are
using for the causes of death. Hong Kong Death Registry data
have been used in many studies and have been found to be of
good quality.14 The sample size was large and we had a large
number of current smokers and former smokers, especially
women, which allowed us to conduct separate analyses for each
sex and test the effect of quitting. The successful follow-up rate
was higher and we adjusted for more potential confounders
than previous studies.
In conclusion, the present study showed significantly higher
risks of death from all causes, cancer, CVDs and respiratory
diseases among current smokers and former smokers for both
male and female older people in Hong Kong, and quitting
smoking was beneficial in reducing these risks. Smoking
cessation, including in elderly smokers, should be an urgent
public health priority in Hong Kong and also in other
developing countries, especially in mainland China and in
other rapidly ageing populations in the East.
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